Pillstats
Rx only · Injection, Solution · Epidural

Bupivacaine Hydrochloride

Brands: Bupivacine Hcl · Marcaine · Marvona Suik · Marvona-25 Suik +1 · Bupivacaine Hydrochloride

15 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US69 NDCs
15 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1815
US makers16 labelers
Packages91
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

19K38K57K76K2025 Q12025 Q22025 Q32025 Q42026 Q1
45K
Rx · 2026 Q1
1.2M
Units dispensed
-31%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it15 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hospira, Inc.unknown14SUPPLYING
Camber Pharmaceuticals, Inc.unknown13SUPPLYING
Fresenius Kabi USA, LLCunknown12SUPPLYING
NorthStar RxLLCunknown9SUPPLYING
Asclemed USA, Inc.unknown6SUPPLYING
ONESOURCE SPECIALTY PHARMA LIMITEDunknown6SUPPLYING
Xellia Pharmaceuticals USA LLCunknown6SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown6SUPPLYING
Eugia US LLCunknown6SUPPLYING
Henry Schein Inc.unknown3SUPPLYING
Fosun Pharma USA Incunknown2SUPPLYING
Anthea Pharma Private Limitedunknown2SUPPLYING
ProPharma Distributionunknown2SUPPLYING
Sportpharm LLCunknown2SUPPLYING
Cardinal Health 107, LLCunknown1SUPPLYING

+ 1 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 13, 2022
    RECALLRecall (Class II): Bupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials x 50 mL per box, Rx only, MFG: Pfizer, NDC 0409-1163-01

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.

  • Apr 13, 2022
    RECALLRecall (Class II): Bupivacaine HCl Injection, single dose vial, Preservative Free 0.5%, 10mL (25/ct), Rx only, Manufacturer: Auromedics Ph…

    cGMP deviations: Temperature abuse — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — USA nationwide.

  • May 3, 2021
    RECALLRecall (Class I): 0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg/30 mL (5 mg/mL), 30 mL Single-dose Teartop Vials (NDC 0409-1162-1…

    Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP — Recalling firm: PFIZER, INC — Nationwide in the USA, Puerto Rico, and Guam

  • Feb 20, 2018
    SHORTAGEDrug shortage: Bupivacaine Hydrochloride Injection (ONESOURCE SPECIALTY PTE LTD)

    Bupivacaine Hydrochloride Injection — reported in shortage by ONESOURCE SPECIALTY PTE LTD. Therapeutic category: Anesthesia.

  • Feb 20, 2018
    SHORTAGEDrug shortage: Bupivacaine Hydrochloride Injection (Aspiro Pharma Limited)

    Bupivacaine Hydrochloride Injection — reported in shortage by Aspiro Pharma Limited. Therapeutic category: Anesthesia.

  • Feb 20, 2018
    SHORTAGEDrug shortage: Bupivacaine Hydrochloride Injection (Kindos Pharmaceuticals Co. Ltd.)

    Bupivacaine Hydrochloride Injection — reported in shortage by Kindos Pharmaceuticals Co. Ltd.. Therapeutic category: Anesthesia.

  • Feb 20, 2018
    SHORTAGEDrug shortage: Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (Hospira, Inc., a Pfizer Company)

    Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Anesthesia.

  • Feb 20, 2018
    SHORTAGEDrug shortage: Bupivacaine Hydrochloride Injection (Hospira, Inc., a Pfizer Company)

    Bupivacaine Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Analgesia/Addiction, Anesthesia.

  • Feb 20, 2018
    SHORTAGEDrug shortage: Bupivacaine Hydrochloride Injection (Eugia US LLC)

    Bupivacaine Hydrochloride Injection — reported in shortage by Eugia US LLC. Therapeutic category: Anesthesia.

  • Sep 16, 2016
    RECALLRecall (Class II): Marcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 mL (2.5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, …

    Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency. — Recalling firm: Hospira Inc., A Pfizer Company — Nationwide and Puerto Rico

  • Sep 16, 2016
    RECALLRecall (Class II): Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg/50 mL (5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc…

    Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency. — Recalling firm: Hospira Inc., A Pfizer Company — Nationwide and Puerto Rico

  • Aug 4, 2016
    RECALLRecall (Class I): Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, …

    Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial. — Recalling firm: Hospira Inc., A Pfizer Company — Nationwide

  • Apr 23, 2015
    RECALLRecall (Class I): Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC.…

    Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles. — Recalling firm: Hospira Inc. — U.S. Nationwide including Guam.

  • Sep 4, 2014
    RECALLRecall (Class II): Bupivacaine HCl Inj., USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative-Free, For Nerve Block, Caudal, and Epidural A…

    Presence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial. — Recalling firm: Hospira Inc. — Nationwide

  • Jun 17, 2014
    RECALLRecall (Class I): Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira, …

    Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution. — Recalling firm: Hospira Inc. — Nationwide

  • Apr 21, 2014
    RECALLRecall (Class I): Marcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (25 mg) Single-dose Vial, Rx only, Hospira, …

    Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution. — Recalling firm: Hospira Inc. — Nationwide.

  • Feb 10, 2014
    RECALLRecall (Class II): Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial, Rx Only, Hospira, Inc., Lake Forest…

    Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the glass vial. — Recalling firm: Hospira Inc. — Nationwide

  • Oct 18, 2013
    RECALLRecall (Class I): Marcaine (bupivacaine HCl) injection, USP, 0.25%, 30 mL single-dose vials-preservative free, packaged in 10-count vials…

    Presence of Particulate Matter: Units of this lot may have visible metal particles embedded in the vial and in the solution causing the product to be discolored. — Recalling firm: Hospira Inc. — Nationwide

  • Oct 11, 2013
    RECALLRecall (Class II): 0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 50 mL, Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Fo…

    Lack of assurance of sterility; equipment failure led to potential breach in asceptic process. — Recalling firm: Hospira Inc. — US Nationwide.

  • Sep 5, 2013
    RECALLRecall (Class II): 0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 10 mL, Single-Dose Vial, NDC 0409-9045-01, Hospira, Inc., Lake For…

    Lack of Assurance of Sterility; potential for vial breakage — Recalling firm: Hospira Inc. — Nationwide and Guam and Abu Dhabi

  • Jul 12, 2013
    RECALLRecall (Class I): 0.25% Bupivacaine HCl Injection, USP, 2.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1159…

    Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials. — Recalling firm: Hospira Inc. — Nationwide

  • Jul 12, 2013
    RECALLRecall (Class I): 0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165…

    Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials. — Recalling firm: Hospira Inc. — Nationwide